DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.01), Zacks reports.
DiaMedica Therapeutics Price Performance
Shares of NASDAQ DMAC opened at $5.99 on Tuesday. The stock has a fifty day moving average price of $5.96 and a 200 day moving average price of $5.09. DiaMedica Therapeutics has a 1-year low of $2.14 and a 1-year high of $6.82. The company has a market cap of $256.14 million, a PE ratio of -10.70 and a beta of 1.52.
DiaMedica Therapeutics Company Profile
Featured Stories
- Five stocks we like better than DiaMedica Therapeutics
- How to Invest in Blue Chip Stocks
- Taiwan Semiconductor Valuation: How Realistic Is the Price?
- Stock Splits, Do They Really Impact Investors?
- Microsoft’s AI Strategy Eases Analyst Concerns—Is It a Buy?
- What is MarketRank™? How to Use it
- CrowdStrike Stock Attracts Congressional Buyers—Time to Invest?
Receive News & Ratings for DiaMedica Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaMedica Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.